Plotting a Treatment Course for EGFR-Mutated NSCLC: Nursing Considerations and Skill-Based Training for Oncology Nurses and NPs

Goal Statement
This activity aims to improve learners’ knowledge and competence in the nursing management of patients with non-small-cell lung cancer who are receiving or eligible for EGFR-targeted treatment. 

Target Audience
This activity has been designed to meet the educational needs of nurse practitioners, oncology nurses, and other healthcare professionals who care for patients with non-small-cell lung cancer. 

Learning Objectives
Upon completion of this event, participants should be able to:

• Explain practical testing for the early detection and identification of actionable EGFR mutations, including interpreting results and implications for treatment planning
• Differentiate the mechanisms of action of tyrosine kinase inhibitors, bispecific antibodies, and other EGFR-targeted agents approved for EGFR-mutated NSCLC
• Provide supportive care for patients receiving EGFR-targeted treatment for EGFR-mutated NSCLC, taking into account patient-specific considerations and emphasizing strategies to improve outcomes and quality of life
• Identify and manage treatment-related AEs associated with EGFR-targeted therapies in patients with EGFR-mutated NSCLC, utilizing evidence-based strategies to minimize patient discomfort and optimize therapeutic outcomes